Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Components of Stock-based Compensation Expense

The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):

	Three Months Ended October 31,				Nine Months Ended October 31,
	2022		2021		2022		2021
Cost of revenue	$	2,835	$	1,202	$	7,082	$	2,425
Research and development	13,996		9,035		37,954		24,997
Sales and marketing	12,166		4,848		28,977		10,800
General and administrative	16,690		12,277		44,305		23,970
Total	$	45,687	$	27,362	$	118,318	$	62,192

Schedule of Nonvested Restricted Stock Shares Activity

A summary of our RSU activity is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2022	1,770,304	$	52.51
Granted	10,251,563	31.34
Released	(705,256)	40.84
Forfeited	(457,402)	39.20
Outstanding as of October 31, 2022	10,859,209	$	33.86

Schedule of Share-based Payment Arrangement, Option, Activity

A summary of our stock option activity is as follows:

	Number of Options	Weighted-Average Exercise Price
Outstanding as of January 31, 2022	42,422,473	$	4.30
Granted	—	—
Exercised	(4,623,806)	2.44
Forfeited	(1,753,185)	4.03
Assumed options from Attivo acquisition	378,828	1.31
Outstanding as of October 31, 2022	36,424,310	$	4.52
Expected to vest as of October 31, 2022	36,424,310	4.52
Vested and exercisable as of October 31, 2022	20,401,824	$	3.27